Oxford, CT, United States of America

Dongmei Liu

USPTO Granted Patents = 2 


Average Co-Inventor Count = 12.5

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Dongmei Liu

Introduction

Dongmei Liu is a prominent inventor based in Oxford, CT (US). He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. With a total of 2 patents to his name, Liu's work focuses on innovative solutions for medical challenges.

Latest Patents

Liu's latest patents include groundbreaking inventions such as anti-PD-1 antibodies. This invention relates to new anti-PD-1 (Programmed cell death 1) antibodies and antigen-binding fragments for therapeutic and diagnostic methods. Another notable patent is for anti-Sema3A antibodies, which target semaphorin 3A (Sema3A). This invention outlines methods of using these antibodies for the treatment of various eye or ocular diseases.

Career Highlights

Dongmei Liu is currently associated with Boehringer Ingelheim International GmbH, where he continues to advance his research and development efforts. His work has the potential to impact the treatment of various diseases significantly.

Collaborations

Liu collaborates with talented coworkers, including Priyanka Gupta and Fei Han, who contribute to his innovative projects.

Conclusion

Dongmei Liu's contributions to the field of biotechnology through his patents and collaborations highlight his role as a key inventor in developing therapeutic solutions. His work continues to pave the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…